| Serial Number | 97353799 |
| Word Mark | AOBIOME |
| Filing Date | Friday, April 8, 2022 |
| Status | 748 - STATEMENT OF USE - TO EXAMINER |
| Status Date | Saturday, January 18, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 7, 2023 |
| Goods and Services | Medicated gels for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; medicated creams for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; medicated sprays for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; nasal sprays for therapeutic use; topical applications in the nature of gels, creams, sprays, and liquids for therapeutic use, namely, topical preparations containing ammonia oxidizing bacteria for the treatment of skin disorders, acne, inflammation, eye disorders, migraines, headaches, allergic reactions, insomnia, hypertension, thermoregulation, and to promote wound healing; medicated liquids for therapeutic use in the nature of therapeutic pharmaceuticals for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; biological therapeutics being pharmaceutical preparations for treatment of skin disorders, circulatory and cardiovascular disorders, neurologic diseases, inflammation, gastrointestinal disorders, respiratory disorders, eye disorders, urogenital disorders, auditory disorders, migraines, headaches, allergic rhinitis, insomnia, hyperhidrosis, acne, and hypertension; therapeutic agents for thermoregulation and promoting wound healing |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, April 12, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | Thursday, September 12, 2024 |
| First Use In Commerce Date | Thursday, September 12, 2024 |
| Party Name | AOBIOME LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Cambridge, MA 02138 |
| Party Name | AOBIOME LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Cambridge, MA 02140 |
| Event Date | Event Description |
| Tuesday, April 12, 2022 | NEW APPLICATION ENTERED |
| Tuesday, April 12, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, January 26, 2023 | ASSIGNED TO EXAMINER |
| Friday, January 27, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 15, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 7, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 7, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 2, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, October 24, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, October 24, 2023 | SOU EXTENSION 1 FILED |
| Tuesday, October 24, 2023 | SOU EXTENSION 1 GRANTED |
| Thursday, October 26, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, May 2, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, May 2, 2024 | SOU EXTENSION 2 FILED |
| Thursday, May 2, 2024 | SOU EXTENSION 2 GRANTED |
| Friday, May 3, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, October 31, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, October 31, 2024 | SOU EXTENSION 3 FILED |
| Thursday, October 31, 2024 | SOU EXTENSION 3 GRANTED |
| Thursday, October 31, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, November 1, 2024 | USE AMENDMENT FILED |
| Friday, November 1, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Friday, January 17, 2025 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Saturday, January 18, 2025 | STATEMENT OF USE PROCESSING COMPLETE |